Physician profile
Subba Rao
NPI 1518053909
$1,392.70
in general payments reported to CMS, 2019-2025
17 companies · $34.64 in 2025
The $34.64 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $64.74 · 2021: $173 · 2022: $195 · 2023: $426 · 2024: $218 · 2025: $34.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $538.99 | 2019-2024 | Invega Trinza, Invega Sustenna |
| Idorsia Pharmaceuticals US INC | $175.17 | 2023 | Quviviq |
| Supernus Pharmaceuticals, INC. | $107.58 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $105.57 | 2019-2023 | Jornay Pm |
| Tris Pharma INC | $98.61 | 2022-2023 | Dyanavel Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $94.24 | 2022-2025 | Caplyta |
| Almatica Pharma LLC | $44.02 | 2023 | Loreev Xr |
| Abbvie INC. | $41.76 | 2021-2022 | |
| Corium, LLC | $39.80 | 2023-2024 | Azstarys |
| Bausch Health US, LLC | $32.30 | 2022 | |
| Allergan, INC. | $31.50 | 2019 | |
| Axsome Therapeutics, INC. | $16.70 | 2023 | Sunosi |
| Avanir Pharmaceuticals, INC. | $14.57 | 2019 | |
| Neos Therapeutics, LP | $13.49 | 2020 | |
| Vertical Pharmaceuticals, LLC | $13.07 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $12.76 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subba Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.